BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7458059)

  • 1. Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis.
    Nickerson BG; Lemen RJ; Gerdes CB; Wegmann MJ; Robertson G
    Am Rev Respir Dis; 1980 Dec; 122(6):859-66. PubMed ID: 7458059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small airway involvement in cystic fibrosis lung disease: routine spirometry as an early and sensitive marker.
    Bakker EM; Borsboom GJ; van der Wiel-Kooij EC; Caudri D; Rosenfeld M; Tiddens HA
    Pediatr Pulmonol; 2013 Nov; 48(11):1081-8. PubMed ID: 23401260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between parameters of volumetric capnography and spirometry during a submaximal exercise protocol on a treadmill in patients with cystic fibrosis and healthy controls.
    Parazzi PLF; Marson FAL; Ribeiro MAGO; Schivinski CIS; Ribeiro JD
    Pulmonology; 2019; 25(1):21-31. PubMed ID: 29954708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of salbutamol on gas compression in cystic fibrosis and asthma.
    Desmond KJ; Demizio DL; Allen PD; MacDonald ND; Coates AL
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):673-7. PubMed ID: 8118635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective and Objective Assessments of Flow-Volume Curve Configuration in Children and Young Adults.
    Weiner DJ; Forno E; Sullivan L; Weiner GA; Kurland G
    Ann Am Thorac Soc; 2016 Jul; 13(7):1089-95. PubMed ID: 27070374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Short-Term Effect of Breathing Tasks Via an Incentive Spirometer on Lung Function Compared With Autogenic Drainage in Subjects With Cystic Fibrosis.
    Sokol G; Vilozni D; Hakimi R; Lavie M; Sarouk I; Bat-El Bar ; Dagan A; Ofek M; Efrati O
    Respir Care; 2015 Dec; 60(12):1819-25. PubMed ID: 26374905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sources of variation in FEV1.
    Coates AL; Desmond KJ; Demizio D; Allen PD
    Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 1):439-43. PubMed ID: 8306042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transit time analysis of the forced expiratory vital capacity in cystic fibrosis.
    Neuburger N; Levison H; Kruger K
    Am Rev Respir Dis; 1976 Oct; 114(4):753-9. PubMed ID: 970749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric capnography as a tool to detect early peripheric lung obstruction in cystic fibrosis patients.
    Ribeiro MÂ; Silva MT; Ribeiro JD; Moreira MM; Almeida CC; Almeida-Junior AA; Ribeiro AF; Pereira MC; Hessel G; Paschoal IA
    J Pediatr (Rio J); 2012; 88(6):509-17. PubMed ID: 23269106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic Fibrosis.
    Vilozni D; Lavie M; Ofek M; Sarouk I; Bar-Aluma BE; Dagan A; Ashkenazi M; Segel MJ; Efrati O
    Ann Am Thorac Soc; 2016 Jun; 13(6):825-32. PubMed ID: 27219817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung function in cystic fibrosis: acute effect of salbutamol.
    Svenonius E; Arborelius M; Kautto R; Kornfält R; Lindberg T
    Respiration; 1980; 40(4):226-32. PubMed ID: 7221194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cough characteristics and FVC maneuver in cystic fibrosis.
    Vilozni D; Lavie M; Ofek M; Sarouk I; Efrati O
    Respir Care; 2014 Dec; 59(12):1912-7. PubMed ID: 25249647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements in lung function and height among cohorts of 6-year-olds with cystic fibrosis from 1994 to 2012.
    VanDevanter DR; Pasta DJ; Konstan MW
    J Pediatr; 2014 Dec; 165(6):1091-1097.e2. PubMed ID: 25134852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximal expiratory flows after postural drainage.
    Feldman J; Traver GA; Taussig LM
    Am Rev Respir Dis; 1979 Feb; 119(2):239-45. PubMed ID: 434596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in lung function does not predict future decline in lung function in cystic fibrosis patients.
    Rosenfeld M; VanDevanter DR; Ren CL; Elkin EP; Pasta DJ; Konstan MW; Morgan WJ;
    Pediatr Pulmonol; 2015 Sep; 50(9):856-62. PubMed ID: 26086901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in spirometry during consecutive admissions for infective pulmonary exacerbations in adolescent and adult cystic fibrosis.
    Packe GE; Hodson ME
    Respir Med; 1992 Jan; 86(1):45-8. PubMed ID: 1565817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time point to perform lung function tests evaluating the effects of an airway clearance therapy session in cystic fibrosis.
    Rodriguez Hortal MC; Hjelte L
    Respir Care; 2014 Oct; 59(10):1537-41. PubMed ID: 24847094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spirometry in 3- to 6-year-old children with cystic fibrosis.
    Marostica PJ; Weist AD; Eigen H; Angelicchio C; Christoph K; Savage J; Grant D; Tepper RS
    Am J Respir Crit Care Med; 2002 Jul; 166(1):67-71. PubMed ID: 12091173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a handheld turbine spirometer to conventional spirometry in children with cystic fibrosis.
    Avdimiretz N; Wilson D; Grasemann H
    Pediatr Pulmonol; 2020 Jun; 55(6):1394-1399. PubMed ID: 32203645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical ventilatory constraints during incremental exercise in healthy and cystic fibrosis children.
    Borel B; Leclair E; Thevenet D; Beghin L; Gottrand F; Fabre C
    Pediatr Pulmonol; 2014 Mar; 49(3):221-9. PubMed ID: 23765600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.